Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy

Molecular Genetics and Metabolism

Volumn 81, Issue 4, 2004, Pages 273-281

  Relton, Caroline L ^a,b   Wilding, Craig S ^b   Laffling, Alison J ^b   Jonas, Pat A ^c   Burgess, Terry ^c   Binks, Keith ^b   Tawn, E Janet ^b   Burn, John ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b WESTLAKES RESEARCH INSTITUTE   (United Kingdom)

^c WEST CUMBERLAND HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Folate; Neural tube defect; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE REDUCTASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CALCULATION; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

ADULT; CASE-CONTROL STUDIES; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; NEURAL TUBE DEFECTS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

UNIDENTIFIED AGENTS;

EID: 1842418757     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.12.010     Document Type: Article

References (40)

1. MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council vitamin study, Lancet 338 (1991) 131-137.
2. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1992;1832-1835.
3. 12 metabolism in families with spina bifida offspring. Q. J. Med. 90:1997;505-510.
4. Daly L.E., Kirke P.N., Molloy A.M., Weir D.G., Scott J.M. Folate levels and neural tube defects: implications for prevention. J. Am. Med. Assoc. 272:1995;1698-1702.
5. Molloy A.M., Mills J.L., Kirke P.N., Ramsbottom D., McPartlin J.M., Burke H., Conley M., Whitehead A.S., Weir D.G., Scott J.M. Low blood folates in NTD pregnancies are only partly explained by thermolabile methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am. J. Genet. 78:1998;155-159.
6. Bailey L.B., Gregory J.F. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J. Nutr. 129:1999;919-922.
7. Nelen W.L.D.M., Blom H.J., Thomas C.M.G., Steegers E.A.P., Boers G.H.J., Eskes T.K.A.B. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J. Nutr. 128:1998;1336-1341.
8. Mitchell L.E., Duffy D.L., Duffy P., Bellingham G., Martin N.G. Genetic effects on variation in red-blood-cell folate in adults: implications for the familial aggregation of neural tube defects. Am. J. Hum. Genet. 60:1997;433-438.
9. Van der Put N.M.J., Gabreels F., Stevens E.M.B., Smeitink J.A.M., Trijbels F.J.M., Eskes T.K.A.B., van den Heuvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am. J. Hum. Genet. 62:1998;1044-1051.
10. Christensen B., Arbour L., Tran P., Leclerc D., Sabbaghian N., Platt R., Gilfix B.M., Rosenblatt D.S., Gravel R.A., Forbes P., Rozen R. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells and risk of neural tube defects. Am. J. Med. Genet. 84:1999;151-157.
11. 12) increases risk for spina bifida. Mol. Genet. Metab. 67:1999;317-323.
12. Chango A., Emery-Fillon N., Potier de Courcy G., Lambert D., Pfister M., Rosenblatt D.S., Nicolas J.-P. A polymorphism (80G. → A) in the reduced folate carrier gene and its association with folate status and homocysteinemia Mol. Genet. Metab. 70:2000;310-315.
13. Dekou V., Gudnason V., Hawe E., Miller G.J., Stansbie D., Humphries S.E. Gene-environment and gene-gene interaction in the determination of plasma homocysteine in healthy middle-aged men. Thromb. Haemost. 85:2001;67-74.
14. Richter B., Stegmann K., Roper B., Boddeker I., Ngo E.T.K.M., Koch M.C. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J. Hum. Genet. 46:2001;105-109.
15. Shaw G.M., Lammer E.J., Zhu H., Baker M.-W., Neri E., Finnell R.H. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (G80A), and risk of spina bifida. Am. J. Med. Genet. 108:2002;1-6.
16. Afman L.A., Lievers K.J.A., Kluijtmans L.A.J., Trijbels F.J.M., Blom H.J. Gene-gene interaction between the cystathionine-β-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C. → T polymorphism on homocysteine levels and risk for neural tube defects Mol. Genet. Metab. 78:2003;211-215.
17. Van der Put N.M.J., Steegers-Theunissen R.P.M., Frosst P., Trijbels F.J.M., Eskes T.K.A.B., van den Heuvel L.P., Mariman E.C.M., den Heyer M., Rozen R., Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
18. Whitehead A.S., Gallagher P., Mills J.L., Kirke P.N., Burke H., Molloy A.M., Weir D.G., Sheilds D.C., Scott J.M. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88:1995;763-766.
19. Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151:2000;862-877.
20. Speer M.C., Nye J., McLone D., Worley G., Melvin E.C., Viles K.D., Franklin A., Drake C., Mackey J., George T.M. NTD Collaborative Group, Possible interaction of genotypes at cystathionine β-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. Clin. Genet. 56:1999;142-144.
21. Heil S.G., Van der Put N.M.J., Waas E.T., den Heijer M., Trijbels F.J.M., Blom H.J. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol. Genet. Metab. 73:2001;164-172.
22. Gaughan D.J., Kluijtmans L.A.J., Barbaux S., McMaster D., Young I.S., Yarnell J.W.G., Evans A., Whitehead A.S. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 157:2001;451-456.
23. Zhu H., Wicker N.J., Shaw G.M., Lammer E.J., Hendricks K., Suarez L., Canfield M., Finnell R.H. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol. Genet. Metab. 78:2003;216-221.
24. Molloy A.M. Is impaired folate absorption a factor in neural tube defects? Am. J. Clin. Nutr. 73:2000;3-4.
25. Shields D.C., Kirke P.N., Mills J.L., Ramsbottom D., Molloy A.M., Burke H., Weir D.G., Scott J.M., Whitehead A.S. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64:1999;1045-1055.
26. Doolin M.-T., Barbaux S., McDonnell M., Hoess K., Whitehead A.S., Mitchell L. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am. J. Hum. Genet. 71:2002;1222-1226.
27. Brody L.C., Conley M., Cox C., Kirke P.N., McKeever M.P., Mills J.L., Molloy A.M., O'Leary V.B., Parle-McDermott A., Scott J.M., Swanson D.A. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the birth defect research group. Am. J. Hum. Genet. 71:2002;1207-1215.
28. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 71:2000;121-138.
29. Chase D.S., Tawn E.J., Parker L., Jonas P., Parker C.O., Burn J. The North Cumbria community genetics project. J. Med. Genet. 35:1998;413-416.
30. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijmans L.A., van den Heuval L.P.et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
31. Brown C.A., McKinney K.Q., Kaufman J.S., Gravel R.A., Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J. Cardiovasc. Risk. 7:2000;197-2000.
32. Ramsbottom D., Scott J.M., Molloy A.M., Weir D.G., Kirke P.N., Mills J.L., Gallagher P.M., Whitehead A.S. Are common mutations of cystathionine-β-synthase involved in the aetiology of neural tube defects? Clin. Genet. 51:1997;39-42.
33. Morrison K., Papapetrou C., Hol F.A., Mariman E.C.M., Lynch S.-A., Burn J., Edwards Y.H. Susceptibility to spina bifida; an association study of five candidate genes. Ann. Hum. Genet. 62:1998;379-396.
34. Ou C.Y., Stevenson R.E., Brown V.K., Schwartz C.E., Allen W.P., Khoury M.J., Rozen R., Oakley G.P. Jr. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism is a risk factor for neural tube defects. Am. J. Med. Genet. 63:1996;610-614.
35. De Franchis R., Buoninconti A., Mandato C., Pepe A., Sperandeo M.P., Del Gado R., Capra V., Salvaggio E., Andria G., Mastroicovo P. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J. Med. Genet. 35:1998;1009-1013.
36. Mornet E., Muller F., Lenvoise-Furet A., Delezoide A.-L., Col J.-Y., Simon-Bouy B., Serre J.-L. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum. Genet. 100:1997;512-514.
37. Papapetrou C., Lynch S.-A., Burn J., Edwards Y.H. Methylenetetrahydrofolate reductase and neural tube defects. Lancet. 348:1996;58.
38. Lucock M., Daskalakis I., Hinkins M., Yates Z. An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol. Genet. Metab. 73:2001;322-332.
39. De Franchis R., Botto L.D., Sebastio G., Ricci R., Iolascon A., Capra V., Andria G., Mastroiacovo P. Spina bifida and folate-related genes: a study of gene-gene interactions. Genet. Med. 4:2002;126-130.
40. Bagley P.J., Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc. Natl. Acad. Sci. USA. 95:1998;13217-13220.